Corpus Intelligence IC Memo — PORTSMOUTH REGIONAL HOSPITAL 2026-04-26 07:38 UTC
IC Memo — PORTSMOUTH REGIONAL HOSPITAL
Investment Committee Memorandum | NH | 168 beds | Grade C | EBITDA uplift $25.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PORTSMOUTH REGIONAL HOSPITAL

CCN 300029 | ROCKINGHAM, NH | 168 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PORTSMOUTH REGIONAL HOSPITAL is a 168-bed suburban community hospital in ROCKINGHAM, NH with $347.4M in net patient revenue and a 45.5% operating margin. The hospital serves a payer mix of 38.8% Medicare, 3.7% Medicaid, and 57.5% commercial.

Thesis: Turnaround. Our ML models identify $25.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 45.5% to 52.8% (+736bps).

Net Revenue HCRIS$347.4M
Current EBITDA COMPUTED$158.0M
Operating Margin COMPUTED45.5%
Occupancy HCRIS80.6%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS17.3%
Distress Probability ML39.1%

2. Market Context & Competitive Position

30
NH Hospitals
-2.7%
State Median Margin
11
Comparable Hospitals

NH has 30 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of 45.5% places it above the state median. Among 11 size-comparable peers (84-336 beds), the median margin is -3.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (84-336), prioritizing same-state peers. 11 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PORTSMOUTH REGIONAL HOSPITAL (Target)NH168$347.4M45.5%
ELLIOT HOSPITALNH215$660.8M14.5%
CONCORD HOSPITAL INC.NH206$553.5M-5.1%
WENTWORTH DOUGLASS HOSPITALNH118$500.9M10.7%
CATHOLIC MEDICAL CENTERNH262$470.4M-4.2%
SOUTHERN NH MEDICAL CENTERNH138$293.0M-0.8%
EXETER HOSPITAL INC.NH99$282.0M-3.2%
ST. JOSEPH HOSPITALNH160$236.2M-15.1%
CHESHIRE MEDICAL CENTERNH86$236.2M-22.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $25.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.3M+210bp18mo
Cost to Collect4.5%2.5%$6.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.2M+122bp9mo
Clean Claim Rate88.0%96.0%$222K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.3M
Cost to Collect
$6.9M
Denial Rate Reduction
$6.9M
A/R Days Reduction
$4.2M
Clean Claim Rate
$222K
Total EBITDA Uplift$25.6M
Current EBITDA$158.0M
+ RCM Uplift+$25.6M
Pro Forma EBITDA$183.6M
Current Margin45.5%
Pro Forma Margin52.8%
WC Released (1x)$13.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$243.1M$1.30B5.34x39.8%
Base (11x exit)10.0x11.0x$243.1M$1.51B6.20x44.0%
Bull Case9.0x11.0x$218.8M$1.67B7.63x50.2%
Bull (12x exit)9.0x12.0x$218.8M$1.89B8.62x53.9%
Bear Case11.0x10.0x$267.4M$1.09B4.08x32.5%
Bear (11x exit)11.0x11.0x$267.4M$1.29B4.81x36.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 11 hospitals with 84-336 beds
  • Same-state prioritization (n=12)
  • Comp margins: P25=-10.7% / P50=-3.7% / P75=-0.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.